Description

ALLEGRA 120 MG

Indications

ALLEGRA 120 MG, containing the active ingredient fexofenadine hydrochloride, is primarily indicated for the relief of symptoms associated with seasonal allergic rhinitis, commonly known as hay fever. These symptoms include sneezing, runny or itchy nose, and itchy or watery eyes. Additionally, ALLEGRA is effective in the treatment of chronic idiopathic urticaria, a condition characterized by the presence of hives without an identifiable cause. The medication is suitable for adults and children aged 12 years and older.

Mechanism of Action

Fexofenadine, the active component of ALLEGRA, is a second-generation antihistamine that selectively antagonizes peripheral H1 receptors. By blocking the action of histamine, a substance in the body that causes allergic symptoms, fexofenadine helps alleviate the effects of allergens. Unlike first-generation antihistamines, fexofenadine does not readily cross the blood-brain barrier, which minimizes central nervous system side effects such as sedation. This selectivity allows for effective symptom relief without significant drowsiness.

Pharmacological Properties

ALLEGRA 120 MG is rapidly absorbed after oral administration, with peak plasma concentrations occurring approximately 2 to 3 hours post-dose. The bioavailability of fexofenadine is approximately 40%, and it is primarily excreted unchanged in the feces, with only a small percentage eliminated via the urine. The elimination half-life of fexofenadine is approximately 14.4 hours, allowing for once-daily dosing in most patients. The drug is not significantly metabolized by the liver, making it a suitable option for patients with liver impairment.

Contraindications

ALLEGRA 120 MG is contraindicated in patients with a known hypersensitivity to fexofenadine or any of the excipients in the formulation. Caution should be exercised in individuals with severe renal impairment, as the pharmacokinetics of fexofenadine may be altered in these patients. It is also not recommended for use in children under 12 years of age without medical advice.

Side Effects

Common side effects associated with ALLEGRA 120 MG include headache, dizziness, and gastrointestinal disturbances such as nausea and diarrhea. Although fexofenadine is less sedating than first-generation antihistamines, some patients may still experience mild drowsiness or fatigue. Rare but serious side effects include allergic reactions such as rash, itching, or swelling, particularly of the face, tongue, or throat. Patients should be advised to seek medical attention if they experience any severe or persistent side effects.

Dosage and Administration

The recommended dosage of ALLEGRA 120 MG for adults and children aged 12 years and older is one tablet taken orally once daily, preferably before a meal. It is important to swallow the tablet whole with water and not to exceed the recommended dose. For patients with renal impairment, a dose adjustment may be necessary, and it is advisable to consult a healthcare professional for appropriate guidance.

Interactions

Fexofenadine may interact with certain medications and substances. The use of antacids containing aluminum or magnesium within two hours of taking ALLEGRA may reduce the absorption of fexofenadine, leading to decreased efficacy. Additionally, the concurrent use of other antihistamines or medications that cause sedation should be approached with caution to avoid additive effects. Patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter drugs and herbal supplements.

Precautions

Before starting treatment with ALLEGRA 120 MG, patients should be evaluated for any history of allergies or hypersensitivity reactions. Caution is advised in patients with pre-existing medical conditions, particularly those affecting the liver or kidneys. Special consideration should also be given to patients who are pregnant or breastfeeding, as the safety of fexofenadine in these populations has not been fully established. It is important for patients to avoid operating heavy machinery or driving if they experience drowsiness or dizziness while taking this medication.

Clinical Studies

Clinical studies have demonstrated the efficacy and safety of ALLEGRA 120 MG in treating allergic rhinitis and chronic urticaria. In randomized, double-blind, placebo-controlled trials, patients reported significant improvements in symptoms such as sneezing, nasal congestion, and itchy eyes after treatment with fexofenadine compared to placebo. The results indicated that ALLEGRA effectively reduces the severity of allergic symptoms with a favorable safety profile, making it a preferred choice among second-generation antihistamines.

Conclusion

ALLEGRA 120 MG is a well-established antihistamine that provides effective relief from the symptoms of seasonal allergic rhinitis and chronic idiopathic urticaria. Its selective action on peripheral H1 receptors minimizes side effects, particularly sedation, making it suitable for daily use. Patients should follow the recommended dosage and consult with healthcare providers regarding any potential interactions or contraindications. Overall, ALLEGRA 120 MG is a valuable option for individuals seeking relief from allergic symptoms.